risk assessment of psa recurrent prostate cancer
Published 1 month ago • 2.4K plays • Length 27:01Download video MP4
Download video MP3
Similar videos
-
23:30
psa recurrence, risk assessment - 2021 prostate cancer patient conference
-
21:09
evaluation and management of psa recurrence after definitive treatment of localized prostate cancer
-
48:23
recurrent prostate cancer cases - 2021 prostate cancer patient conference
-
22:55
recurrent prostate cancer cases panel
-
17:05
psma targeting for treatment of advanced prostate cancer - 2021 prostate cancer patient conference
-
27:06
‘do not go and castrate yourself’, nutrition expert on understanding prostate cancer
-
15:48
active surveillance for prostate cancer
-
11:54
chemotherapy and radioligand therapy for advanced prostate cancer
-
34:43
prostate cancer: evaluation and management of low risk disease
-
16:45
untreated metastatic prostate cancer - 2021 prostate cancer patient conference
-
17:43
management of oligometastatic prostate cancer: from imaging to therapy
-
19:27
prostate cancer: the abcs of initial evaluation
-
9:30
new treatments for advanced prostate cancer
-
19:04
functional imaging and recurring prostate cancer
-
15:37
adt resistant metastatic prostate cancer (mcrpc) - 2021 prostate cancer patient conference
-
14:20
prostate cancer epidemiology, screening and diagnosis - 2021 prostate cancer patient conference
-
47:12
results of a prostate cancer/vitamin d trial: effectiveness safety recommendations
-
24:19
demystifying clinical trials in prostate cancer
-
13:34
immunotherapy and advanced prostate cancer
-
58:49
what you need to know about prostate cancer